Bee, snake, and scorpion venom have cancer-fighting properties
the ONA take:
Finding reported at the 248th National Meeting of the American Chemical Society (ACS) suggest that bee, snake, or scorpion venom may be able to be used to fight cancer.
According to lead investigator Dipanjan Pan, Ph.D., the venom toxins within nanometer-sized particles were able to treat breast cancer and melanoma cells in vitro by remaining hidden from the immune system, thereby sparing normal cells and only killing cancer cells. This method eliminates adverse effects that venom toxins would typically cause.
Venom from these animals contains biological molecules that can attach to cancer cell membranes which would stop the growth and spread cancer. Because simply injecting venom into a patient would cause serious adverse effects like clotting, heart muscle or nerve cell damange, or bleeding under the skin, the anti-tumor substances within the venom had to be identified. One of those substances, melittin was chemically synthesized and inserted into nanoparticles.
The nanoparticles keep the toxin from seeping into the bloodstream and causing adverse effects. Pan says that the nanoparticles then go to the tumor where they attach to cancer stem cells, thereby blocking proliferation.
Future studies will evaluate this new method in rats and pigs, but Pan and his team hope they will eventually study the approach in patients in the next 3 to 5 years.
Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs.
The report was part of the 248th National Meeting of the American Chemical Society (ACS), the world's largest scientific society.
The meeting, attended by thousands of scientists, features nearly 12,000 reports on new advances in science and other topics. It is being held here through Thursday.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|